Back to results

University of Texas Health Science Center at Houston

Targeting Epigenetic Regulators For The Treatment of Diffuse Large B-Cell Lymphoma

Abstract

dc:description.abstract

<p>Small-molecule inhibitors of the histone methyltransferase EZH2 hold great promise for the treatment of Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma (GCB-DLBCL). Compared to a 60% Objective Response Rate (ORR) in Phase I clinical trials, Phase II trial results for the EZH2 inhibitor EPZ-6438 reported an attenuation of response. Mechanisms contributing to lymphoma cell survival and growth after EZH2 ablation are poorly studied. In EZH2-mutant cells, we found that B-Cell Receptor (BCR) signaling was enhanced after EZH2 inhibitor treatment, and associated with an activated B-cell phenotype. Genetic manipulation of BCR, CD19 and CD79A greatly increased sensitivity to the EZH2 inhibitor EPZ-6438. Combination therapy with SYK, PI3Kdelta and BTK kinase inhibitors was highly synergistic in multiple lymphoma cell lines, regardless of EZH2 mutation status. At the epigenetic level, prolonged treatment with EPZ-6438 increased global levels of Histone H4 Arginine-3 asymmetric di-methylation. In a subset of lymphoma cell lines, combination therapy with EZH2 and Type I PRMT inhibitors showed synergy. Interestingly, Type I PRMT inhibitors were also highly effective as a single-agent, and mediated apoptosis in lymphoma cells by transcriptionally down-regulating the anti-apoptotic protein BCL2. To summarize, we have identified ways to improve EZH2 inhibitor sensitivity in DLBCL cells and revealed a critical role for the arginine methyltransferase PRMT1 in the regulation of lymphoma growth and survival. Therefore, PRMT1 presents a novel and promising target for the treatment of this cancer type.</p>

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Level thesis:degree_level
Dissertation (PhD)
Year dc:date.available
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Goverdhan, Aarthi
  • <p><a href="http://orcid.org/0000-0002-7879-7748" target="_blank">0000-0002-7879-7748</a></p>
Contributors dc:contributor
  • Mien-Chie Hung, Ph.D.
  • Mark T. Bedford, Ph.D.
  • Paul J. Chiao, Ph.D.

Subjects

dc:subject × 6

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1829

Chain of custody

source
Harvested from
University of Texas Health Science Center at Houston
Base URL
digitalcommons.library.tmc.edu/do/oai/
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Goverdhan, Aarthi; <p><a href="http://orcid.org/0000-0002-7879-7748" target="_blank">0000-0002-7879-7748</a></p>. Targeting Epigenetic Regulators For The Treatment of Diffuse Large B-Cell Lymphoma. Dissertation (PhD) thesis, 2017. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/787